<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on XOMA from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated XOMA news from BioPortfolio.com</description>
	<pubDate>Tue, 09 Feb 2010 13:11:05 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=XOMA" rel="self" type="application/rss+xml" />

	
<item><title>XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in Type 2 Diabetes Patients</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034573&amp;HITNO=0&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034573&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535869394%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034573&amp;HITNO=0&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034573&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535869394%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in Type 2 Diabetes Patients</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034567&amp;HITNO=1&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034567&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535865250%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034567&amp;HITNO=1&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034567&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535865250%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in Type 2 Diabetes Patients</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034679&amp;HITNO=2&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034679&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535918473%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034679&amp;HITNO=2&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034679&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535918473%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>DMN Newswire:</description></item>
<item><title>XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in Type 2 Diabetes Patients</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034539&amp;HITNO=3&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034539&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535845600%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034539&amp;HITNO=3&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034539&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535845600%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Stockwatch:</description></item>
<item><title>XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in Type 2 Diabetes Patients</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034532&amp;HITNO=4&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034532&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535841609%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034532&amp;HITNO=4&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034532&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535841609%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>NewsBlaze:</description></item>
<item><title>XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034607&amp;HITNO=5&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034607&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535881134%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034607&amp;HITNO=5&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034607&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535881134%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GlobeNewswire via MSN Money:</description></item>
<item><title>XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in Type 2 Diabetes Patients</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034558&amp;HITNO=6&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034558&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535860585%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034558&amp;HITNO=6&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034558&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535860585%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GlobeNewswire via Yahoo!:</description></item>
<item><title>XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in Type 2 Diabetes Patients</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034620&amp;HITNO=7&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034620&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535891360%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034620&amp;HITNO=7&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034620&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535891360%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Individual.com:</description></item>
<item><title>XOMA Announces Presentation at BIO CEO and Investor Conference on February 9</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4014590&amp;HITNO=8&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4014590&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524064159%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4014590&amp;HITNO=8&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4014590&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524064159%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>XOMA Announces Presentation at BIO CEO and Investor Conference on February 9</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013090&amp;HITNO=9&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013090&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523607841%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013090&amp;HITNO=9&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013090&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523607841%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>XOMA:</description></item>
<item><title>XOMA Announces Presentation at BIO CEO and Investor Conference on February 9</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010161&amp;HITNO=10&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010161&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522271381%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010161&amp;HITNO=10&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010161&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522271381%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>NewsBlaze:</description></item>
<item><title>XOMA Announces Presentation at BIO CEO and Investor Conference on February 9</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4011461&amp;HITNO=11&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4011461&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522946441%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4011461&amp;HITNO=11&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4011461&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522946441%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Tech Divas:</description></item>
<item><title>PicksThatMove.com Announces Investment Opinion on Iteration Energy, IBC Advanced Alloys Corp., Xoma Ltd., Adventrix Pharmaceuticals Inc. and Bonanza Oil &amp; Gas Inc.</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010746&amp;HITNO=12&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010746&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522600133%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010746&amp;HITNO=12&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010746&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522600133%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>SmartBrief:</description></item>
<item><title>PicksThatMove.com Announces Investment Opinion on Iteration Energy, IBC Advanced Alloys Corp., Xoma Ltd., Adventrix Pharmaceuticals Inc. and Bonanza O</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4009952&amp;HITNO=13&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4009952&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522168094%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4009952&amp;HITNO=13&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4009952&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522168094%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>PicksThatMove.com Announces Investment Opinion on Iteration Energy, IBC Advanced Alloys Corp., Xoma Ltd., Adventrix Pharmaceuticals Inc. and Bonanza Oil &amp; Gas Inc.</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4009517&amp;HITNO=14&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4009517&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522010274%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4009517&amp;HITNO=14&amp;MSIZE=205&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=XOMA&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4009517&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522010274%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Earthtimes.org:</description></item>
</channel></rss>